Jeffrey Robert Ajer

Insider Reports History

Location
San Francisco, CA
Signature
Mark A. Wilson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey Robert Ajer:

Company Role Class Num Shares Value Price $ Report Date Ownership
BIOMARIN PHARMACEUTICAL INC EVP, Chief Commercial Officer Common Stock 66,767 $5,535,652 $82.91 02 May 2024 Direct
Viridian Therapeutics, Inc.\DE Director Stock Option (Right to Buy) 21,000 01 Jul 2025 Direct
NEKTAR THERAPEUTICS Director Stock Option 8,000 30 Sep 2025 Direct

Insider Reports Filed by Jeffrey Robert Ajer

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NKTR NEKTAR THERAPEUTICS 30 Sep 2025 1 $0 4 Director 01 Oct 2025, 19:49
VRDN Viridian Therapeutics, Inc.\DE 01 Jul 2025 1 $0 4 Director 02 Jul 2025, 16:43
VRDN Viridian Therapeutics, Inc.\DE 07 Apr 2025 1 $0 4 Director 09 Apr 2025, 16:26
VRDN Viridian Therapeutics, Inc.\DE 07 Apr 2025 0 $0 3 Director 09 Apr 2025, 16:19
NKTR NEKTAR THERAPEUTICS 31 Dec 2024 1 $0 5 Director 17 Jan 2025, 20:30
BMRN BIOMARIN PHARMACEUTICAL INC 02 May 2024 2 -$393,956 4 EVP, Chief Commercial Officer 06 May 2024, 16:40
BMRN BIOMARIN PHARMACEUTICAL INC 15 Mar 2024 1 -$1,893,785 4 EVP, Chief Commercial Officer 19 Mar 2024, 20:36
BMRN BIOMARIN PHARMACEUTICAL INC 05 Mar 2024 1 -$348,280 4 EVP, Chief Commercial Officer 07 Mar 2024, 17:32
BMRN BIOMARIN PHARMACEUTICAL INC 27 Feb 2024 3 $0 4 EVP, Chief Commercial Officer 29 Feb 2024, 17:12
NKTR NEKTAR THERAPEUTICS 18 Sep 2023 2 -$3,008 4 Director 20 Sep 2023, 21:06
BMRN BIOMARIN PHARMACEUTICAL INC 16 Aug 2023 2 -$428,733 4 EVP, Chief Commercial Officer 17 Aug 2023, 16:57
BMRN BIOMARIN PHARMACEUTICAL INC 15 Mar 2023 4 -$2,264,255 4 EVP, Chief Commercial Officer 17 Mar 2023, 21:16
BMRN BIOMARIN PHARMACEUTICAL INC 28 Feb 2023 3 $0 4 EVP, Chief Commercial Officer 02 Mar 2023, 15:09
BMRN BIOMARIN PHARMACEUTICAL INC 25 Jan 2023 5 -$2,346,444 4 EVP, Chief Commercial Officer 27 Jan 2023, 20:35
BMRN BIOMARIN PHARMACEUTICAL INC 02 Nov 2022 1 -$258,360 4 EVP, Chief Commercial Officer 04 Nov 2022, 17:25
NKTR NEKTAR THERAPEUTICS 23 Sep 2022 1 -$13,266 4 Director 26 Sep 2022, 19:25
NKTR NEKTAR THERAPEUTICS 16 Sep 2022 2 $0 4 Director 20 Sep 2022, 20:41
BMRN BIOMARIN PHARMACEUTICAL INC 11 Aug 2022 1 -$286,860 4 EVP, Chief Commercial Officer 12 Aug 2022, 19:07
BMRN BIOMARIN PHARMACEUTICAL INC 03 Jun 2022 1 -$544,057 4 EVP, Chief Commercial Officer 07 Jun 2022, 14:46
BMRN BIOMARIN PHARMACEUTICAL INC 29 Apr 2022 2 -$82,035 4 EVP, Chief Commercial Officer 31 May 2022, 21:29
BMRN BIOMARIN PHARMACEUTICAL INC 13 Apr 2022 1 -$97,315 4 EVP, Chief Commercial Officer 14 Apr 2022, 19:54
BMRN BIOMARIN PHARMACEUTICAL INC 29 Mar 2022 2 -$238,390 4 EVP, Chief Commercial Officer 31 Mar 2022, 21:28
BMRN BIOMARIN PHARMACEUTICAL INC 22 Mar 2022 2 -$669,143 4 EVP, Chief Commercial Officer 24 Mar 2022, 20:49
BMRN BIOMARIN PHARMACEUTICAL INC 15 Mar 2022 4 -$762,764 4 EVP, Chief Commercial Officer 17 Mar 2022, 21:11
BMRN BIOMARIN PHARMACEUTICAL INC 08 Mar 2022 1 $0 4 EVP, Chief Commercial Officer 10 Mar 2022, 16:00
NKTR NEKTAR THERAPEUTICS 22 Sep 2021 3 -$65,164 4 Director 24 Sep 2021, 18:12
BMRN BIOMARIN PHARMACEUTICAL INC 30 Apr 2021 2 -$180,247 4 EVP, Chief Commercial Officer 28 Oct 2021, 19:48